Maxx Medical, Pvt. Ltd., a global medical device company, today announced that its newly-developed Stemmed Tibial Baseplate (“Stemmed Tibia”) component for the Freedom Total Knee® System ("Freedom Knee") has received US FDA, European CE Mark and Indian DCGI approvals. The Company is showcasing the Stemmed Tibia during the ICJR-Middle East Conference, which commenced today in Dubai.

Freedom Knee is a complete primary knee replacement system developed collaboratively by leading orthopedic and biomedical design experts to provide multiple component size and proportion configurations that deliver high-flexion motion while conserving bone. The Stemmed Tibia is an additional component option to the Freedom Knee system that can be used during primary or revision knee surgery, according to patient needs. It offers surgeons a new option during surgery to provide additional stability for patients with limited bone stock or extensive bone deformities.

The Stemmed Tibia is one of the most bone conserving, low profile stemmed baseplates available on the market. It offers all of the benefits of Freedom Knee’s innovative tibial baseplate locking mechanism technology, plus additional features including:

-Stability - Designed to resist baseplate lift-off due to tilting that can result from poor bone stock.